Cellular and humoral immunity following vaccination with two different PCV2 vaccines (containing PCV2a or PCV2a/PCV2b) and challenge with virulent PCV2d-Reference-Cited by-同舟云学术

Cellular and humoral immunity following vaccination with two different PCV2 vaccines (containing PCV2a or PCV2a/PCV2b) and challenge with virulent PCV2d

Published:2021-09 Issue:39 Volume:39 Page:5615-5625
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Venegas-Vargas Cristina,Taylor Lucas P.,Foss Dennis L.,Godbee Traci K.,Philip Ryan,Bandrick Meggan^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference36 articles.

1. Mechanisms of action of adjuvants;Awate;Front Immunol,2013

2. Bandrick, M., Gutiérrez, A.H., Desai, P., Rincon, G., Martin, W.D., Terry, F.E., Groot, A.S.d., Foss, D.L., 2020. T cell epitope content comparison (EpiCC) analysis demonstrates a bivalent PCV2 vaccine has greater T cell epitope overlap with field strains than monovalent PCV2 vaccines. Veterinary Immunol Immunopathol 223.

3. Commercial porcine circovirus type 2 vaccines: efficacy and clinical application;Chae;Veterinary J,2012

4. Squalene emulsion potentiated the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases IL-18, and IFN-g;Desbien;Eur J Immunol,2015

5. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs;Fenaux;J Virol,2004

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of immune effects of porcine circovirus type 2d (PCV2d) capsid protein expressed by Escherichia coli and baculovirus-insect cells;Vaccine;2024-04

2. A porcine circovirus type 2d-based virus-like particle vaccine induces humoral and cellular immune responses and effectively protects pigs against PCV2d challenge;Frontiers in Microbiology;2024-01-11

3. Safety of the Administration of an Inactivated PCV2a/PCV2b/Mycoplasma Hyopneumoniae Vaccine to Pregnant and Lactating Sows and Gilts;Vaccines;2023-09-14

4. Laboratory safety evaluation of lokivetmab, a canine anti-interleukin-31 monoclonal antibody, in dogs;Veterinary Immunology and Immunopathology;2023-04

5. Comparative Efficacy of Chimeric Porcine Circovirus (PCV) Vaccines against Experimental Heterologous PCV2d Challenges;Veterinary Sciences;2023-01-21